Latest filing published 28 Oct 2020 for Perspective Therapeutics, Inc., €8,463.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +45.2%Entry US$4.20 · Close at T+365 US$6.10
- -38.8%Entry US$8.50 · Close at T+365 US$5.20
- +27.3%Entry US$27.32 · Close at T+365 US$34.76
- +35.9%Entry US$19.22 · Close at T+365 US$26.13
- +3.1%Entry US$18.65 · Close at T+365 US$19.22
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael W. McCormick: trading record in brief
Michael W. McCormick discloses dealings in 2 companies, chiefly Columbia Sportswear Co and Perspective Therapeutics, Inc. We count 51 filings; the first trade dates from 7 August 2007 and the latest from 22 October 2020.
On the open market, the record shows 7 purchases worth €387k and 3 sales worth €3.5M. Netting one side against the other leaves €3.2M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 19 share grants and 22 option exercises. Since January 2020: 1 purchase and no sales on the market.
The median purchase comes to €67k. Looking at 7 purchases old enough to measure, the stock rose over the following 90 days in 29% of cases; the median change was -5.9%. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 28 October 2020 with an open-market purchase (€8,463) in Perspective Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael W. McCormick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,230 shares@ US$0.52100.0% of flowCommon StockSEC:0001437749-20-021853:0Canonical exit: 20 Jan 2021 (T+90)
- 22,000 shares@ US$0.86767.2% of flowCommon stockSEC:0001642247-16-000004:0Canonical exit: 6 Jun 2016 (T+90)
- 32,000 shares@ US$40.49Common StockSEC:0001351952-12-000050:0
- 16,950 shares@ US$31.21Common StockSEC:0001351952-12-000050:1
- 13,364 shares@ US$41.23Common StockSEC:0001351952-12-000050:2
- 62,314 shares@ US$52.64Common StockSEC:0001351952-12-000050:3
- 8,080 shares@ US$52.73Common StockSEC:0001351952-12-000050:4
- 12,333 shares@ US$52.43Common StockSEC:0001351952-12-000050:5
- 123 shares0Common StockSEC:0001351952-12-000027:0
- 2,978 shares0Common StockSEC:0001351952-12-000022:0
- 560 shares0Common StockSEC:0001351952-12-000009:0
- 223 shares@ US$46.35Common StockSEC:0001351952-12-000009:1
- 677 shares0Common StockSEC:0001351952-12-000009:2
- 242 shares@ US$46.34Common StockSEC:0001351952-12-000009:3
- 781 shares0Common StockSEC:0001351952-12-000009:4
- 277 shares@ US$46.34Common StockSEC:0001351952-12-000009:5
- 1,189 shares0Common StockSEC:0001351952-12-000009:6
- 422 shares@ US$46.34Common StockSEC:0001351952-12-000009:7
- 381 shares@ US$45.87Common StockSEC:0001351952-12-000004:0
- 392 shares@ US$45.87Common StockSEC:0001351952-12-000002:0
- 123 shares0Common StockSEC:0001351952-11-000030:0
- 960 shares0Common StockSEC:0001351952-11-000026:0
- 677 shares0Common StockSEC:0001351952-11-000013:0
- 269 shares@ US$59.55Common StockSEC:0001351952-11-000013:1
- 781 shares0Common StockSEC:0001351952-11-000013:2
25 of 49 declarations
